Page last updated: 2024-11-10

brassinin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID3035211
CHEMBL ID373777
CHEBI ID38119
SCHEMBL ID849773
MeSH IDM0235438

Synonyms (45)

Synonym
105748-59-2
brassinin ,
methyl (1h-indol-3-ylmethyl)carbamodithioate
methyl (1h-indol-3-ylmethyl)dithiocarbamate
CHEBI:38119 ,
brassinine
UPCMLD-DP058:001
UPCMLD-DP058
SMP2_000288
NCGC00161625-02
NCGC00161625-01
brassinin, 1
methyl n-(1h-indol-3-ylmethyl)carbamodithioate
bdbm24813
n-(1h-indol-3-ylmethyl)(methylsulfanyl)carbothioamide
CHEMBL373777
FT-0663599
ccris 7485
carbamodithioic acid, (1h-indol-3-ylmethyl)-, methyl ester
unii-j2ibo1b8vh
j2ibo1b8vh ,
bsn
CCG-208623
SCHEMBL849773
J-001475
methyl (1h-indol-3-yl)methylcarbamodithioate
AKOS030255507
SR-05000002163-2
sr-05000002163
brassinin, >=98% (hplc)
methyl (1h-indol-3-ylmethyl)carbamodithioate, 9ci
carbamodithioic acid, n-(1h-indol-3-ylmethyl)-, methyl ester
methyl ((1h-indol-3-yl)methyl)carbamodithioate
1h-(indol-3-ylmethyl)-dithiocarbamic acid,methyl ester
carbamodithioic acid,n-(1h-indol-3-ylmethyl)-,methyl ester
Q27117380
BCP33962
brassinine;methyl (1h-indol-3-ylmethyl)carbamodithioate
methyl n-(1h-indol-3-ylmethyl)-carbamodithioate
methyl hydrogen [(1h-indol-3-yl)methyl]carbonodithioimidate
DTXSID30909714
AS-56125
n-[(1h-indol-3-yl)methyl](methylsulfanyl)carbothioamide
HY-111334
CS-0034997

Research Excerpts

Overview

Brassinin is a plant defense metabolite with antimicrobial activity produced de novo by a variety of Brassica species in response to stress. It is an essential phytoalexin due to its antifungal activity and its role as biosynthetic precursor of other phyToalexins.

ExcerptReferenceRelevance
"Brassinin is a phytoalexin produced by crucifer plants as part of a general defense mechanism against pathogens and other forms of stress."( Design, synthesis, and evaluation of potential inhibitors of brassinin glucosyltransferase, a phytoalexin detoxifying enzyme from Sclerotinia sclerotiorum.
Hossain, M; Pedras, MS, 2007
)
1.3
"Brassinin is a plant defense metabolite with antimicrobial activity produced de novo by a variety of Brassica species in response to stress, that is, a phytoalexin. "( Isosteric probes provide structural requirements essential for detoxification of the phytoalexin brassinin by the fungal pathogen Leptosphaeria maculans.
Jha, M; Minic, Z; Okeola, OG; Pedras, MS, 2007
)
2
"Brassinin is an essential phytoalexin due to its antifungal activity and its role as biosynthetic precursor of other phytoalexins produced in plants of the family Brassicaceae (common name crucifer)."( Brassinin oxidase mediated transformation of the phytoalexin brassinin: structure of the elusive co-product, deuterium isotope effect and stereoselectivity.
Minic, Z; Pedras, MS; Sarma-Mamillapalle, VK, 2011
)
2.53
"Brassinin is an essential indole phytoalexin and is a biosynthetic precursor for other phytoalexins."( The combined treatment of brassinin and imatinib synergistically downregulated the expression of MMP-9 in SW480 colon cancer cells.
Bakar-Ates, F; Ozkan, E, 2019
)
1.54
"Brassinin is an antifungal compound induced in Brassica plants after microbial infection. "( The Bdtf1 gene in Alternaria brassicicola is important in detoxifying brassinin and maintaining virulence on Brassica species.
Cho, IK; Cho, Y; Srivastava, A, 2013
)
2.07
"Brassinin (1) is an essential phytoalexin produced in plants of the family Brassicaceae (common name crucifer) due to its role as a biosynthetic precursor of other phytoalexins and antimicrobial activity. "( Synthetic inhibitors of the fungal detoxifying enzyme brassinin oxidase based on the phytoalexin camalexin scaffold.
Minic, Z; Pedras, MS; Sarma-Mamillapalle, VK, 2009
)
2.04
"Brassinin is a plant metabolite of great significance due to its dual role both as an effective phytoalexin and as an early biosynthetic precursor of the majority of the phytoalexins produced by plants of the family Brassicaceae (Cruciferae)."( Camalexin induces detoxification of the phytoalexin brassinin in the plant pathogen Leptosphaeria maculans.
Jha, M; Okeola, OG; Pedras, MS, 2005
)
1.3
"Brassinin is a phytoalexin produced by plants from the family Brassicaceae that displays antifungal activity against a number of pathogens of Brassica species, including Leptosphaeria maculans (Desm.) Ces. "( Detoxification of the phytoalexin brassinin by isolates of Leptosphaeria maculans pathogenic on brown mustard involves an inducible hydrolase.
Gadagi, RS; Jha, M; Pedras, MS; Sarma-Mamillapalle, VK, 2007
)
2.06
"Brassinin is a phytoalexin, a class of natural products derived from plants that includes the widely known compound resveratrol."( A key in vivo antitumor mechanism of action of natural product-based brassinins is inhibition of indoleamine 2,3-dioxygenase.
Banerjee, T; Duhadaway, JB; Gaspari, P; Malachowski, WP; Mellor, AL; Muller, AJ; Munn, DH; Prendergast, GC; Sutanto-Ward, E, 2008
)
1.3
"Cyclobrassinin is a biologically derived product of the oxidative cyclization of brassinin, and was as active as the parent compound in inhibiting the formation of preneoplastic mammary lesions in culture; however, 2-methylbrassinin was not significantly active in this process."( Cancer chemopreventive activity of brassinin, a phytoalexin from cabbage.
Constantinou, A; Gerhüser, C; Hawthorne, M; Liu, J; Mehta, RG; Moon, RC; Moriarty, RM; Pezzuto, JM; Thomas, CF; You, M, 1995
)
1.02

Effects

ExcerptReferenceRelevance
"Brassinin has been demonstrated to have chemopreventive activity in preclinical models but the mechanisms underlying its anticancer properties are unknown."( A key in vivo antitumor mechanism of action of natural product-based brassinins is inhibition of indoleamine 2,3-dioxygenase.
Banerjee, T; Duhadaway, JB; Gaspari, P; Malachowski, WP; Mellor, AL; Muller, AJ; Munn, DH; Prendergast, GC; Sutanto-Ward, E, 2008
)
1.3

Treatment

Brassinin treatment decreased the expression levels of cell adhesion molecules. Pretreatment with brassinin significantly inhibited adhesion of U937 cells to TNF‑α‑induced HUVECs.

ExcerptReferenceRelevance
"Brassinin treatment decreased the expression levels of cell adhesion molecules, including intracellular adhesion molecule‑1 (ICAM‑1), vascular cell adhesion molecule‑1 (VCAM‑1), and endothelial‑selectin (E‑selectin) following stimulation with TNF‑α in HUVECs."( Inhibitory effect of brassinin on TNF‑α‑induced vascular inflammation in human umbilical vein endothelial cells.
Choi, ES; Han, BH; Jeong, DH; Kang, DG; Lee, HS; Lee, YJ; Yoon, JJ, 2017
)
1.5
"Pretreatment with brassinin significantly inhibited adhesion of U937 cells to TNF‑α‑induced HUVECs in a dose‑dependent manner."( Inhibitory effect of brassinin on TNF‑α‑induced vascular inflammation in human umbilical vein endothelial cells.
Choi, ES; Han, BH; Jeong, DH; Kang, DG; Lee, HS; Lee, YJ; Yoon, JJ, 2017
)
1.1

Compound-Compound Interactions

ExcerptReferenceRelevance
" The objective of our study was to analyze the potential synergistic anti-tumor effects of BSN combined with CAP on prostate cancer PC-3 cells."( Brassinin Combined with Capsaicin Enhances Apoptotic and Anti-metastatic Effects in PC-3 Human Prostate Cancer Cells.
Ahn, KS; Kim, SH; Kim, SM; Lee, J; Lee, JH; Lee, SG; Nam, D; Oh, EY; Shim, BS, 2015
)
1.86
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
dithiocarbamic esterAny ester derived from a member of the class of dithiocarbamic acids by formal replacement of the -SH group by -SR, where R is an organyl group.
indole phytoalexin
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (4)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASEHomo sapiens (human)Potency0.39810.003245.467312,589.2998AID2517
Chain A, Ferritin light chainEquus caballus (horse)Potency31.83265.623417.292931.6228AID485281
DNA polymerase kappa isoform 1Homo sapiens (human)Potency44.66840.031622.3146100.0000AID588579
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Indoleamine 2,3-dioxygenase 1Homo sapiens (human)Ki76.35000.09402.37907.0000AID1798475; AID258023; AID568290; AID731011
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (19)

Processvia Protein(s)Taxonomy
regulation of activated T cell proliferationIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
positive regulation of T cell tolerance inductionIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
positive regulation of chronic inflammatory responseIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
positive regulation of type 2 immune responseIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
tryptophan catabolic processIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
inflammatory responseIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
female pregnancyIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
tryptophan catabolic process to kynurenineIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
response to lipopolysaccharideIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
negative regulation of interleukin-10 productionIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
positive regulation of interleukin-12 productionIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
multicellular organismal response to stressIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
kynurenic acid biosynthetic processIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
swimming behaviorIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
T cell proliferationIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
negative regulation of T cell proliferationIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
negative regulation of T cell apoptotic processIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
positive regulation of T cell apoptotic processIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
'de novo' NAD biosynthetic process from tryptophanIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (5)

Processvia Protein(s)Taxonomy
electron transfer activityIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
heme bindingIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
indoleamine 2,3-dioxygenase activityIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
metal ion bindingIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
tryptophan 2,3-dioxygenase activityIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (4)

Processvia Protein(s)Taxonomy
cytosolIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
smooth muscle contractile fiberIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
stereocilium bundleIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
cytoplasmIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (46)

Assay IDTitleYearJournalArticle
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID300476Antifungal activity against Sclerotina sclerotiorum assessed as growth inhibition at 0.30 mM after 48 hrs2007Bioorganic & medicinal chemistry, Sep-01, Volume: 15, Issue:17
Design, synthesis, and evaluation of potential inhibitors of brassinin glucosyltransferase, a phytoalexin detoxifying enzyme from Sclerotinia sclerotiorum.
AID574890Activity of Leptosphaeria maculans BoLm in presence of EAM reagent relative to control2011Bioorganic & medicinal chemistry, Feb-15, Volume: 19, Issue:4
Brassinin oxidase mediated transformation of the phytoalexin brassinin: structure of the elusive co-product, deuterium isotope effect and stereoselectivity.
AID258023Inhibitory activity against human IDO2006Journal of medicinal chemistry, Jan-26, Volume: 49, Issue:2
Structure-activity study of brassinin derivatives as indoleamine 2,3-dioxygenase inhibitors.
AID574895Activity of Leptosphaeria maculans BoLm in presence of IAA reagent relative to control2011Bioorganic & medicinal chemistry, Feb-15, Volume: 19, Issue:4
Brassinin oxidase mediated transformation of the phytoalexin brassinin: structure of the elusive co-product, deuterium isotope effect and stereoselectivity.
AID574884Ratio of kcat to Km for Leptosphaeria maculans BoLm2011Bioorganic & medicinal chemistry, Feb-15, Volume: 19, Issue:4
Brassinin oxidase mediated transformation of the phytoalexin brassinin: structure of the elusive co-product, deuterium isotope effect and stereoselectivity.
AID300477Antifungal activity against Sclerotina sclerotiorum assessed as growth inhibition at 0.10 mM after 48 hrs2007Bioorganic & medicinal chemistry, Sep-01, Volume: 15, Issue:17
Design, synthesis, and evaluation of potential inhibitors of brassinin glucosyltransferase, a phytoalexin detoxifying enzyme from Sclerotinia sclerotiorum.
AID779086Antiproliferative activity against human HeLa cells assessed as cell viability after 72 hrs by MTT assay2013Bioorganic & medicinal chemistry, Nov-01, Volume: 21, Issue:21
The synthesis and anticancer activity of analogs of the indole phytoalexins brassinin, 1-methoxyspirobrassinol methyl ether and cyclobrassinin.
AID697853Inhibition of horse BChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID574889Activity of Leptosphaeria maculans BoLm in presence of BUT reagent relative to control2011Bioorganic & medicinal chemistry, Feb-15, Volume: 19, Issue:4
Brassinin oxidase mediated transformation of the phytoalexin brassinin: structure of the elusive co-product, deuterium isotope effect and stereoselectivity.
AID574894Activity of Leptosphaeria maculans BoLm in presence of EDC reagent relative to control2011Bioorganic & medicinal chemistry, Feb-15, Volume: 19, Issue:4
Brassinin oxidase mediated transformation of the phytoalexin brassinin: structure of the elusive co-product, deuterium isotope effect and stereoselectivity.
AID1082986Drug metabolism in Leptosphaeria maculans isolate BJ-125 assessed as rate of transformation to indole-3-carboxaldehyde at 0.10 mM after 15 hr by HPLC analysis2012Journal of agricultural and food chemistry, Aug-15, Volume: 60, Issue:32
Metabolism and metabolites of dithiocarbamates in the plant pathogenic fungus Leptosphaeria maculans.
AID574886Activity of Leptosphaeria maculans BoLm at 0.05 to 1.0 mM2011Bioorganic & medicinal chemistry, Feb-15, Volume: 19, Issue:4
Brassinin oxidase mediated transformation of the phytoalexin brassinin: structure of the elusive co-product, deuterium isotope effect and stereoselectivity.
AID697852Inhibition of electric eel AChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID779088Antiproliferative activity against human MDA-MB-231 cells assessed as cell viability after 72 hrs by MTT assay2013Bioorganic & medicinal chemistry, Nov-01, Volume: 21, Issue:21
The synthesis and anticancer activity of analogs of the indole phytoalexins brassinin, 1-methoxyspirobrassinol methyl ether and cyclobrassinin.
AID289308Specific activity of Leptosphaeria maculans brassinin oxidase2007Bioorganic & medicinal chemistry, Sep-15, Volume: 15, Issue:18
Isosteric probes provide structural requirements essential for detoxification of the phytoalexin brassinin by the fungal pathogen Leptosphaeria maculans.
AID568290Inhibition of IDO2011Bioorganic & medicinal chemistry, Feb-15, Volume: 19, Issue:4
Indol-2-yl ethanones as novel indoleamine 2,3-dioxygenase (IDO) inhibitors.
AID289306Antifungal activity against Leptosphaeria maculans BJ 125 at 0.20 mM2007Bioorganic & medicinal chemistry, Sep-15, Volume: 15, Issue:18
Isosteric probes provide structural requirements essential for detoxification of the phytoalexin brassinin by the fungal pathogen Leptosphaeria maculans.
AID779085Antiproliferative activity against human A549 cells assessed as cell viability after 72 hrs by MTT assay2013Bioorganic & medicinal chemistry, Nov-01, Volume: 21, Issue:21
The synthesis and anticancer activity of analogs of the indole phytoalexins brassinin, 1-methoxyspirobrassinol methyl ether and cyclobrassinin.
AID731011Inhibition of human recombinant IDO assessed as inhibition of indoleamine 2,3-dioxygenase to kynurenine conversion after 60 mins by HPLC analysis2013Bioorganic & medicinal chemistry, Mar-01, Volume: 21, Issue:5
Synthesis and biological evaluation of novel tryptoline derivatives as indoleamine 2,3-dioxygenase (IDO) inhibitors.
AID574892Activity of Leptosphaeria maculans BoLm in presence of DEPC reagent relative to control2011Bioorganic & medicinal chemistry, Feb-15, Volume: 19, Issue:4
Brassinin oxidase mediated transformation of the phytoalexin brassinin: structure of the elusive co-product, deuterium isotope effect and stereoselectivity.
AID574888Selectivity ratio of compound to dideuterated brassinin for Leptosphaeria maculans BoLm activity2011Bioorganic & medicinal chemistry, Feb-15, Volume: 19, Issue:4
Brassinin oxidase mediated transformation of the phytoalexin brassinin: structure of the elusive co-product, deuterium isotope effect and stereoselectivity.
AID300481Metabolic stability assessed as half life in Sclerotina sclerotiorum2007Bioorganic & medicinal chemistry, Sep-01, Volume: 15, Issue:17
Design, synthesis, and evaluation of potential inhibitors of brassinin glucosyltransferase, a phytoalexin detoxifying enzyme from Sclerotinia sclerotiorum.
AID779090Antiproliferative activity against human MCF7 cells assessed as cell viability after 72 hrs by MTT assay2013Bioorganic & medicinal chemistry, Nov-01, Volume: 21, Issue:21
The synthesis and anticancer activity of analogs of the indole phytoalexins brassinin, 1-methoxyspirobrassinol methyl ether and cyclobrassinin.
AID574896Activity of Leptosphaeria maculans BoLm in presence of PMSF reagent relative to control2011Bioorganic & medicinal chemistry, Feb-15, Volume: 19, Issue:4
Brassinin oxidase mediated transformation of the phytoalexin brassinin: structure of the elusive co-product, deuterium isotope effect and stereoselectivity.
AID1082988Antifungal activity against Leptosphaeria maculans isolate BJ-125/UAMH-9410 assessed as mycelial growth inhibition at 0.1 mM incubated under constant light for 5 days by mycelial radial growth bioassay2012Journal of agricultural and food chemistry, Aug-15, Volume: 60, Issue:32
Metabolism and metabolites of dithiocarbamates in the plant pathogenic fungus Leptosphaeria maculans.
AID289307Antifungal activity against Leptosphaeria maculans BJ 125 at 0.10 mM2007Bioorganic & medicinal chemistry, Sep-15, Volume: 15, Issue:18
Isosteric probes provide structural requirements essential for detoxification of the phytoalexin brassinin by the fungal pathogen Leptosphaeria maculans.
AID779089Antiproliferative activity against human Jurkat cells assessed as cell viability after 72 hrs by MTT assay2013Bioorganic & medicinal chemistry, Nov-01, Volume: 21, Issue:21
The synthesis and anticancer activity of analogs of the indole phytoalexins brassinin, 1-methoxyspirobrassinol methyl ether and cyclobrassinin.
AID779087Antiproliferative activity against human CCRF-CEM cells assessed as cell viability after 72 hrs by MTT assay2013Bioorganic & medicinal chemistry, Nov-01, Volume: 21, Issue:21
The synthesis and anticancer activity of analogs of the indole phytoalexins brassinin, 1-methoxyspirobrassinol methyl ether and cyclobrassinin.
AID276856Cytotoxicity against human HeLa cells at 30 uM2006Bioorganic & medicinal chemistry letters, Dec-15, Volume: 16, Issue:24
Isobrassinin and its analogues: novel types of antiproliferative agents.
AID276858Cytotoxicity against human MCF7 cells at 30 uM2006Bioorganic & medicinal chemistry letters, Dec-15, Volume: 16, Issue:24
Isobrassinin and its analogues: novel types of antiproliferative agents.
AID574893Activity of Leptosphaeria maculans BoLm in presence of WRK reagent relative to control2011Bioorganic & medicinal chemistry, Feb-15, Volume: 19, Issue:4
Brassinin oxidase mediated transformation of the phytoalexin brassinin: structure of the elusive co-product, deuterium isotope effect and stereoselectivity.
AID276860Cytotoxicity against human A431 cells at 30 uM2006Bioorganic & medicinal chemistry letters, Dec-15, Volume: 16, Issue:24
Isobrassinin and its analogues: novel types of antiproliferative agents.
AID289305Antifungal activity against Leptosphaeria maculans BJ 125 at 0.50 mM2007Bioorganic & medicinal chemistry, Sep-15, Volume: 15, Issue:18
Isosteric probes provide structural requirements essential for detoxification of the phytoalexin brassinin by the fungal pathogen Leptosphaeria maculans.
AID574883Activity of Leptosphaeria maculans BoLm2011Bioorganic & medicinal chemistry, Feb-15, Volume: 19, Issue:4
Brassinin oxidase mediated transformation of the phytoalexin brassinin: structure of the elusive co-product, deuterium isotope effect and stereoselectivity.
AID574880Activity of Leptosphaeria maculans BoLm in presence of H218O relative to control2011Bioorganic & medicinal chemistry, Feb-15, Volume: 19, Issue:4
Brassinin oxidase mediated transformation of the phytoalexin brassinin: structure of the elusive co-product, deuterium isotope effect and stereoselectivity.
AID1082987Drug metabolism in Leptosphaeria maculans isolate BJ-125 assessed as drug recovery at 0.10 mM after 24 hr by HPLC analysis2012Journal of agricultural and food chemistry, Aug-15, Volume: 60, Issue:32
Metabolism and metabolites of dithiocarbamates in the plant pathogenic fungus Leptosphaeria maculans.
AID247974In vitro cytotoxic concentration measured against human myelogenous leukemia K562 cells2005Bioorganic & medicinal chemistry letters, Apr-01, Volume: 15, Issue:7
Synthesis and in vitro antitumor activity of 4(3H)-quinazolinone derivatives with dithiocarbamate side chains.
AID1082990Antifungal activity against Leptosphaeria maculans isolate BJ-125/UAMH-9410 assessed as mycelial growth inhibition at 0.5 mM incubated under constant light for 5 days by mycelial radial growth bioassay2012Journal of agricultural and food chemistry, Aug-15, Volume: 60, Issue:32
Metabolism and metabolites of dithiocarbamates in the plant pathogenic fungus Leptosphaeria maculans.
AID574891Activity of Leptosphaeria maculans BoLm in presence of NAI reagent relative to control2011Bioorganic & medicinal chemistry, Feb-15, Volume: 19, Issue:4
Brassinin oxidase mediated transformation of the phytoalexin brassinin: structure of the elusive co-product, deuterium isotope effect and stereoselectivity.
AID1082989Antifungal activity against Leptosphaeria maculans isolate BJ-125/UAMH-9410 assessed as mycelial growth inhibition at 0.2 mM incubated under constant light for 5 days by mycelial radial growth bioassay2012Journal of agricultural and food chemistry, Aug-15, Volume: 60, Issue:32
Metabolism and metabolites of dithiocarbamates in the plant pathogenic fungus Leptosphaeria maculans.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).2014Journal of biomolecular screening, Jul, Volume: 19, Issue:6
A High-Throughput Assay to Identify Inhibitors of the Apicoplast DNA Polymerase from Plasmodium falciparum.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).
AID1798475Enzyme Inhibition Assay from Article 10.1021/jm0508888: \\Structure-activity study of brassinin derivatives as indoleamine 2,3-dioxygenase inhibitors.\\2006Journal of medicinal chemistry, Jan-26, Volume: 49, Issue:2
Structure-activity study of brassinin derivatives as indoleamine 2,3-dioxygenase inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (57)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's4 (7.02)18.2507
2000's19 (33.33)29.6817
2010's28 (49.12)24.3611
2020's6 (10.53)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 24.37

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index24.37 (24.57)
Research Supply Index4.08 (2.92)
Research Growth Index5.11 (4.65)
Search Engine Demand Index26.67 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (24.37)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (3.45%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other56 (96.55%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]